Savage, MN Gets Expanded Access to Premium Physical Therapy as Family Physical Therapy Relocates to Larger Facility

Savage, MN Gets Expanded Access to Premium Physical Therapy as Family Physical Therapy Relocates to Larger Facility GlobeNewswire June 05, 2025 TWIN CITIES, Minn., June 05, 2025 (GLOBE NEWSWIRE) — Family Physical Therapy of Savage, MN is excited to announce our relocation to the former Finish Line Wellness space! As a premium healthcare facility, we […]

Accelsius Strengthens Presence in European Data Centers with Global Switch Collaboration and London Showcase

Accelsius Strengthens Presence in European Data Centers with Global Switch Collaboration and London Showcase GlobeNewswire June 05, 2025 AUSTIN, Texas, June 05, 2025 (GLOBE NEWSWIRE) — Accelsius, a leader in two-phase, direct-to-chip liquid cooling technology, today announced its latest European milestone: the deployment of a Thermal Simulation Rack at Global Switch's newly built London showroom.

Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025

Upstream Bio to Present Mechanistic Insights into Verekitug's Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 GlobeNewswire June 05, 2025 WALTHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) — Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on

Rubicon Organics Acquires Hope Facility to Accelerate Premium Cannabis Growth Strategy

Rubicon Organics Acquires Hope Facility to Accelerate Premium Cannabis Growth Strategy GlobeNewswire June 05, 2025 VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) — June 5, 2025 – Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products,

USA Rare Earth Announces Appointment of David Bushi as Senior Vice President of Manufacturing

USA Rare Earth Announces Appointment of David Bushi as Senior Vice President of Manufacturing GlobeNewswire June 05, 2025 STILLWATER, Okla., June 05, 2025 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced the appointment of David Bushi as Senior Vice President of Manufacturing. In this role, Mr. Bushi will

Attention Craft Beer Fans! Tilray Beverages Highlights Boldest Brews For Summer

Attention Craft Beer Fans! Tilray Beverages Highlights Boldest Brews For Summer Explore Craft Beers from Atwater Brewery, Blue Point Brewing, Breckenridge Brewery, Montauk Brewing, Shock Top, SweetWater Brewing Co., Terrapin Beer Co., and Widmer Brother's Brewing–Perfectly Crafted for the Sunny Season GlobeNewswire June 05, 2025 ATLANTA, June 05, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc.

Giyani Announces Board Update

Giyani Announces Board Update GlobeNewswire June 05, 2025 TORONTO, June 05, 2025 (GLOBE NEWSWIRE) — Giyani Metals Corp. (TSXV:EMM, GR:A2DUU8) (“Giyani” or the “Company“), developer of the K.Hill battery-grade manganese project in Botswana (“K.Hill” or “the Project“), announces the appointments of Nigel Robinson as in-coming Chair and Martin Botha to its board of directors (the

NexGold Infill Drilling Intersects 11.87 g/t Gold Over 6.1 Metres and 3.77 g/t Gold Over 9.1 Metres at the Goldboro Gold Project

NexGold Infill Drilling Intersects 11.87 g/t Gold Over 6.1 Metres and 3.77 g/t Gold Over 9.1 Metres at the Goldboro Gold Project GlobeNewswire June 05, 2025 TORONTO, June 05, 2025 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company“) is pleased to provide an update on its ongoing 25,000-metre diamond

Sachem Capital Corp. Announces Common and Preferred Dividends

Sachem Capital Corp. Announces Common and Preferred Dividends GlobeNewswire June 05, 2025 BRANFORD, Conn., June 05, 2025 (GLOBE NEWSWIRE) — Sachem Capital Corp. (NYSE American: SACH) (the “Company”), a real estate lender specializing in originating, underwriting, funding, servicing, and managing a portfolio of loans secured by first mortgages on real property, announced today that its

Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis

Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis GlobeNewswire June 05, 2025 – KPL-387 Phase 2/3 trial on track to initiate in mid-2025; Phase 2 data expected in 2H 2026 –– KPL-387 Phase 1 single ascending dose data support profile for monthly dosing –– Presentation and webcast

Scroll to Top